Key result
Local anesthetics dissociate platelet aggregation from clot retraction, as dibucaine inhibits retraction without affecting aggregation.
This preclinical study demonstrates that platelet aggregation can be mechanistically dissociated from clot retraction, potassium permeability, and ATPase activity.
Answers are grounded in this paper and cite their sources.
Does not support altering antiplatelet therapy; leaves open selective targeting of platelet functions for future study.
Six out of 10 local anesthetics inhibited clot retraction, platelet aggregation, and ATPase activity; and produced platelet potassium loss. Another anesthetic, dibucaine, inhibited clot retraction but did not inhibit platelet aggregation. Thus these two phenomena were separable. Dibucaine, however, produced platelet potassium loss and inhibited ATPase activity. These studies have shown that platelet aggregation may be dissociated from clot retraction, changes in platelet permeability to potassium and ATPase activity.
No takes yet. Share an insight, caveat, or question.
Aledort et al. (1968) studied this question. Local anesthetics (including dibucaine) was evaluated on Platelet aggregation, clot retraction, potassium loss, and ATPase activity. Local anesthetics demonstrated that platelet aggregation can be dissociated from clot retraction, potassium loss, and ATPase activity, as dibucaine inhibited clot retraction without affecting aggregation.
Synapse has enriched 10 related papers. Consider them for comparative context: